In situ surface-enhanced Raman scattering spectroscopy exploring molecular changes of drug-treated cancer cell

Lijia Liang1, Dianshuai Huang, Hailong Wang

  • 1State Key Laboratory of Supramolecular Structure and Materials, Institute of Theoretical Chemistry, Jilin University , Changchun 130012, People's Republic of China.

Analytical Chemistry
|January 21, 2015
PubMed

Insights

This study introduces a novel microspectroscopic technique to analyze molecular changes within cancer cell nuclei after drug treatment. The method aids in understanding drug mechanisms and developing new cancer therapies.

Area of Science:

  • Biomedical Optics
  • Molecular Spectroscopy
  • Cancer Research

Background:

  • Understanding cancer cell nucleus molecular changes is vital for anticancer drug design and therapy.
  • Accurate in situ molecular information acquisition within cell nuclei is necessary to comprehend drug effects.
  • Current methods may lack the resolution or specificity for detailed nuclear drug interaction studies.

Purpose of the Study:

  • To develop and demonstrate a microspectroscopic technique for in situ analysis of molecular changes in cancer cell nuclei upon drug treatment.
  • To investigate the molecular-level effects of DNA binders and anticancer drugs on Soma Gastric Cancer (SGC-7901) cell nuclei.
  • To establish a method for real-time monitoring of cellular dynamics influenced by exogenous molecules.

Main Methods:

  • Utilized dark-field and fluorescence co-imaging assisted surface-enhanced Raman scattering (SERS) spectroscopy.
  • Developed nuclear targeting nanoprobes (gold nanorods with PEG and NLS) for amplified SERS signals.
  • Performed in situ SERS spectral analysis on SGC-7901 cell nuclei treated with Hoechst33342 and doxorubicin (Dox).

Main Results:

  • Successfully achieved amplified SERS signals from biomolecules within cell nuclei using targeted nanoprobes.
  • Disclosed molecular-level effects of Hoechst33342 and Dox on key biomolecules in SGC-7901 cell nuclei.
  • Demonstrated the capability of the technique for simultaneous location and spectral acquisition within a single cell nucleus.

Conclusions:

  • The developed dark-field/fluorescence co-imaging assisted SERS technique is effective for in situ nuclear molecular analysis.
  • This method shows significant potential for investigating new anticancer drug targets and mechanisms.
  • The technique enables real-time monitoring of dynamic cellular changes induced by exogenous compounds.

Related Concept Videos